This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2024
APCCC 2024
EAU 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
SUO 2016
Bladder Cancer
Germline Genetics
Kidney Cancer
Prostate Cancer
Testicular Cancer
Highlights from SUO 2016 Annual Meeting
Viewing 36-55 of 57 articles
SUO 2016: Imaging Modalities to Detect Metastatic Disease - Session Highlights
SUO 2016: Renal Dysfunction and the Kidney Cancer Patient - Session Highlights
SUO 2016: State of the Art lecture: Genomic profiling and clinical implications of atypical intermediate prostate cancer phenotype - Session Highlights
SUO 2016: Factors Predicting Skeletal-Related Events in Patients with Bone Metastatic Castration-Resistant Prostate Cancer - Poster Session Highlights
SUO 2016: Percutaneous Biopsy of Renal Masses and the Role in Kidney Cancer Management - Session Highlights
SUO 2016: Addressing patient expectations - Session Highlights
SUO 2016: Imaging and focal therapy: reliable enough? - Session Highlights
SUO 2016: Results of clinical trials in prostate partial gland ablation therapies - Session Highlights
SUO 2016: Partial gland ablation and focal therapies: current consensus and the SUO - Session Highlights
SUO 2016: The platinum study: clinical translational research in testicular cancer survivors - Session Highlights
SUO 2016: Clinical implications for prostate cancer screening and treatment of men with germline mutations in BRCA and other DNA repair genes - Session Highlights
SUO 2016: Germline susceptibility for bladder cancer- Session Highlights
SUO 2016: Inherited DNA-repair gene mutations in men with metastatic prostate cancer - Session Highlights
SUO 2016: Prostate SNPs: Clinical applicability for screening and chemoprevention - Session Highlights
SUO 2016: Germline Implications of Somatic Profiling - Session Highlights
SUO 2016: Genomic classifier test impacts treatment decision-making among patients with biomedical recurrence after radical prostatectomy: results from multicenter prospective PR-IMPACT study - Poster Session Highlights
SUO 2016: Discrimination of malignant and benign kidney tissue with 1064 nm dispersive Raman spectroscopy - Poster Session Highlights
SUO 2016: Comparison of surgical margins between open, laparoscopic and robotic partial nephrectomiies in kidney cancer in a population based cohort - Poster Session Highlights
SUO 2016: Accountable Care Organizations, Urologist Practice Affiliation and Prostate Cancer - Poster Session Highlights
SUO 2016: Association of Single Nucleotide Polymorphisms with Renal Cell Carcinoma Metastases in Patients with Dual Diagnoses of Renal Cell Carcinoma and Melanoma - Poster Session Highlights
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
